Back to search
Congenital Microtia
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Congenital Microtia trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Congenital Microtia trials you may qualify forThis study aims to improve surgical outcomes for children and young adults with ear differences severe secondary to congenital conditions (like microtia, a cond…
Nutritional status is a measurable and modifiable factor that is often not considered during treatment and its clinical impact undervalued due in part to the he…
Among people living with HIV, heavy drinking increases the risk of heart disease and death. Studies suggest that alcohol changes the number and kind of bacteria…
This is a randomized double-blind placebo-controlled parallel group superiority clinical trial among 94 pregnant women (47 in each group) to investigate the eff…
The aim of this study is to compare speech perception in noise with one activated Osia (unilateral) versus two activated Osia (bilateral), in children with high…
AUR-201 is indicated for the treatment of Grade II, III, or IV unilateral microtia in patients 8 to 29 years of age.
Long-term follow-up of unilateral microtia patients implanted with AUR-201.